Llwytho...
Naltrexone/Bupropion: An Investigational Combination for Weight Loss and Maintenance
Naltrexone/bupropion is an investigational combination for weight loss and maintenance in patients who are obese or have a BMI ≧ 27 kg/m(2) with comorbid diabetes, hypertension or hyperlipidemia. Pooled results from four phase 3 trials reveal placebo-subtracted mean weight loss of 4.7% (range 3.2–5....
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Obes Facts |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
S. Karger AG
2011
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444555/ https://ncbi.nlm.nih.gov/pubmed/22249001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000335352 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|